Patents by Inventor Fergal O'Brien
Fergal O'Brien has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 12248508Abstract: Methods, systems, and devices are described for providing selectable content offerings to mobile users via mobile terminals over a satellite system. In embodiments, a database of access profiles for accessing a network via the satellite system may be maintained. Each access profile corresponds to a respective content category of a plurality of content categories and is associated with a respective set of content sources available via the network. Devices may be provided with a respective set of content categories for display based at least in part on a device-specific profile associated with the corresponding device. In embodiments, a request is received from particular device for a particular content category. An access profile may be identified from the database that is associated with the particular content offering. Communications may be permitted between the device and the respective set of content sources associated with the content category associated with the access profile.Type: GrantFiled: September 16, 2020Date of Patent: March 11, 2025Assignee: Viasat, Inc.Inventors: Ultan O'Brien, Niall O'Sullivan, Fergal Murray
-
Publication number: 20240091409Abstract: A nerve regeneration device comprising a bioresorbable conduit and a matrix contained therein having elongate pores aligned with the longitudinal axis of the conduit. The matrix comprises collagen, fibronectin, laminin-1, and laminin-2, wherein the amount, by weight, of laminin-1 or laminin-2 is greater than the amount of fibronectin in the matrix.Type: ApplicationFiled: November 30, 2023Publication date: March 21, 2024Inventors: Fergal O'Brien, Alan Hibbitts, Simon James Archibald
-
Patent number: 11844877Abstract: A nerve regeneration device comprising a bioresorbable conduit and a matrix contained therein having elongate pores aligned with the longitudinal axis of the conduit. The matrix comprises collagen, fibronectin, laminin-1, and laminin-2, wherein the amount, by weight, of laminin-1 or laminin-2 is greater than the amount of fibronectin in the matrix.Type: GrantFiled: April 5, 2021Date of Patent: December 19, 2023Assignee: Integra LifeSciences CorporationInventors: Fergal O'Brien, Alan Hibbitts, Simon James Archibald
-
Publication number: 20230285280Abstract: The present invention relates to a device for use in the delivery of an active agent. Specifically, the present invention relates to a device comprising a scaffold that can be formed from a polymer or copolymer; a matrix; and at least one active agent. The device finds utility in the delivery of at least one active agent, and is useful in methods of reducing cell infiltration, inflammation and collagen deposition in a tissue or treating fibrosis in a tissue. In an aspect, the device can alleviate post-operative inflammation and/or fibrosis; and can also improve patient compliance for effective delivery of an active agent.Type: ApplicationFiled: June 26, 2021Publication date: September 14, 2023Inventors: ALAN HIBBITTS, RIFFINGTON LEMOINE, FERGAL O'BRIEN, COLM O'BRIEN
-
Patent number: 11730479Abstract: The present invention is directed to a nerve regeneration conduit including a resorbable tube having a matrix therein. The matrix is characterized by substantially parallel, axially aligned pores extending the length of the matrix. The matrix is formed by the axial freezing of a slurry having little or no significant radial thermal gradient during the freezing process. The matrix is used to bridge the gap between the severed ends of a nerve and provide a scaffold for nerve regeneration.Type: GrantFiled: November 8, 2021Date of Patent: August 22, 2023Assignee: Integra LifeSciences CorporationInventors: Simon J. Archibald, Fergal O'Brien, Amos Matsiko
-
Publication number: 20230001052Abstract: A method of producing an acellular peripheral nerve graft comprises the steps of providing a section of peripheral nerve, primary treatment of the section of peripheral nerve comprising freezing and then thawing the section of peripheral nerve, freeze-drying the thawed section of peripheral nerve longitudinally to introduce longitudinal pores into the section of peripheral nerve, and decellularization of the section of peripheral nerve comprising contacting the freeze-dried section of peripheral nerve with detergent and enzymatic decellularization agents to provide the acellular peripheral nerve graft. 9. The acellular peripheral nerve graft typically has an average pore size of at least 40 ?m and a DNA content of less than 100 ng/mg.Type: ApplicationFiled: November 27, 2020Publication date: January 5, 2023Applicants: THE PROVOST, FELLOWS, SCHOLARS AND OTHER MEMBERS OF BOARD OF TRINITY COLLEGE DUBLIN, ROYAL COLLEGE OF SURGEONS IN IRELANDInventors: Conor BUCKLEY, Leyla ZILIC, Fergal O'BRIEN
-
Publication number: 20220401619Abstract: A collagen scaffold for the delivery of bioactive agents such as antimicrobials comprising a first collagen matrix layer and a second collagen matrix layer in which the first collagen matrix layer comprises a first bioactive agent physically entrapped in the first collagen matrix layer and the second collagen matrix layer comprises a second bioactive agent chemically attached to the second collagen matrix layer for an initial high concentration elution of antimicrobial from the first collagen matrix layer followed by a sustained release from the second collagen matrix layer to prevent re-infection.Type: ApplicationFiled: November 25, 2020Publication date: December 22, 2022Applicant: ROYAL COLLEGE OF SURGEONS IN IRELANDInventors: Fergal O'BRIEN, Amro WIDAA, Adolfo LOPEZ-NORIEGA, Alan RYAN, Eamon SHEEHY
-
Publication number: 20220064378Abstract: A star polypeptide for use as a medicament, the star polypeptide comprising or consisting of a core and polypeptide arms radiating from the core. The star polypeptide may be used to deliver a therapeutic cargo and/or for its intrinsic properties. Therapeutic cargoes include a protein(e.g. VEGF); a nucleic acid (e.g. in vitro transcribed mRNA or microRNA); and/or a drug (e.g. diclofenac, azithromycin and/or rifampicin). Intrinsic properties include osteogenesis, angiogenesis and inhibition of bacteria.Type: ApplicationFiled: December 23, 2019Publication date: March 3, 2022Inventors: Sally-Ann Cryan, Andreas Heise, David Walsh, Joanne O'Dwyer, Fergal O'Brien, Garry Duffy
-
Publication number: 20220054134Abstract: The present invention is directed to a nerve regeneration conduit including a resorbable tube having a matrix therein. The matrix is characterized by substantially parallel, axially aligned pores extending the length of the matrix. The matrix is formed by the axial freezing of a slurry having little or no significant radial thermal gradient during the freezing process. The matrix is used to bridge the gap between the severed ends of a nerve and provide a scaffold for nerve regeneration.Type: ApplicationFiled: November 8, 2021Publication date: February 24, 2022Inventors: Simon J. Archibald, Fergal O'Brien, Amos Matsiko
-
Patent number: 11179157Abstract: The present invention is directed to a nerve regeneration conduit including a resorbable tube having a matrix therein. The matrix is characterized by substantially parallel, axially aligned pores extending the length of the matrix. The matrix is formed by the axial freezing of a slurry having little or no significant radial thermal gradient during the freezing process. The matrix is used to bridge the gap between the severed ends of a nerve and provide a scaffold for nerve regeneration.Type: GrantFiled: December 4, 2017Date of Patent: November 23, 2021Assignee: Integra LifeSciences CorporationInventors: Simon J. Archibald, Fergal O'Brien, Amos Matsiko
-
Publication number: 20210308330Abstract: A nerve regeneration device comprising a bioresorbable conduit and a matrix contained therein having elongate pores aligned with the longitudinal axis of the conduit. The matrix comprises collagen, fibronectin, laminin-1, and laminin-2, wherein the amount, by weight, of laminin-1 or laminin-2 is greater than the amount of fibronectin in the matrix.Type: ApplicationFiled: April 5, 2021Publication date: October 7, 2021Inventors: Fergal O'Brien, Alan Hibbitts, Simon James Archibald
-
Publication number: 20190357910Abstract: The present invention is directed to a nerve regeneration conduit including a resorbable tube having a matrix therein. The matrix is characterized by substantially parallel, axially aligned pores extending the length of the matrix. The matrix is formed by the axial freezing of a slurry having little or no significant radial thermal gradient during the freezing process. The matrix is used to bridge the gap between the severed ends of a nerve and provide a scaffold for nerve regeneration.Type: ApplicationFiled: December 4, 2017Publication date: November 28, 2019Inventors: Simon J. Archibald, Fergal O'Brien, Amos Matsiko
-
Publication number: 20060121609Abstract: This invention relates to gradient scaffolds, methods of producing the same, and methods of use thereof, in particular for applications in tissue engineering, repair and regeneration. The gradient scaffolding includes, inter-alia, scaffolds, which are varied in terms of their pore diameter, chemical composition, crosslink density, or combinations thereof, throughout the scaffolding.Type: ApplicationFiled: September 21, 2005Publication date: June 8, 2006Inventors: Ioannis Yannas, Lorna Gibson, Fergal O'Brien, Brendan Harley, Ricardo Brau, Stephen Samouhos, Myron Spector